CORCEPT THERAPEUTICS INC Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Corcept Therapeutics Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Corcept Therapeutics Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $5.73M, a 14.4% increase year-over-year.
  • Corcept Therapeutics Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $24.5M, a 18.8% increase year-over-year.
  • Corcept Therapeutics Inc annual Income Tax Expense (Benefit) for 2023 was $18.4M, a 24.7% increase from 2022.
  • Corcept Therapeutics Inc annual Income Tax Expense (Benefit) for 2022 was $14.8M, a 18.2% increase from 2021.
  • Corcept Therapeutics Inc annual Income Tax Expense (Benefit) for 2021 was $12.5M, a 51.2% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $18.4M +$3.64M +24.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $14.8M +$2.28M +18.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $12.5M -$13.1M -51.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $25.6M +$3.1M +13.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $22.5M +$5.75M +34.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $16.7M +$93.1M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 -$76.3M -$76.3M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.